Skip to content

PPG in the OR and ICU

PPG in the OR and ICU - PPG@OR&ICU

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40811
Enrollment
40
Registered
2014-04-24
Start date
2014-06-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

monitoring van vitale parameters tijdens heelkundige ingrepen (mn die van de buik) vitale parameter monitoring

Interventions

None listed

Sponsors

Philips Research
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria are: adult (>=18 years) patients planned to undergo major abdominal surgery followed by recovery and/or intensive care. These patients are routinely equipped with an iinvasieve arterial blood pressure line and ECG lines.

Exclusion criteria

Exclusion criteria: Exclusion criteria are: neuro-trauma, pregnancy, prone position during surgery or intensive care, obesity (BMI>40), and a significant language barrier that prevents the patient from understanding the Informed Consent.

Design outcomes

Primary

MeasureTime frame
The primary endpoint of the study is the correlation of the effects of blood transfusion, fluid therapy, and vasoactive medication during surgery, recovery, and intensive care with and without mechanical ventilation on the invasively measured arterial blood pressure waveforms and the PPG waveforms non-invasively measured at the finger, ear, and forehead. The secondary endpoint of the study is the assessment of the PPG signal quality from different sensors in terms of information on heart rate, arterial blood saturation, volume status, blood pressure, and early warning for hemodynamic crisis.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)